Access to Health
We are committed to addressing unmet global health needs by leveraging our core competencies, expertise and experience throughout the global health community.
Focusing on low- and middle-income countries, we implement and strengthen holistic programs that expand access to healthcare through a robust strategy, global health partnerships and shared value initiatives. Our Access to Health (A2H) programs and initiatives address local needs, and help to create long-term value for the business, our stakeholders and the environment.
By identifying gaps in public health systems, we find opportunities for sustainable business models designed to ensure that our products and solutions reach patients in an affordable way. This applies to both neglected diseases, such as schistosomiasis and malaria, and non-communicable diseases with high prevalence in these countries.
Committed to Health for All
We rank eighth in the 2021 Access to Medicine (ATM) Index.
Every two years, the Access to Medicine Foundation benchmarks 20 of the world’s largest pharmaceutical companies according to their efforts to advance global access to medicines. Our position among the top ten confirms our continuous commitment to improving sustainable access to high-quality solutions for all. The ATM Index for 2021 recognized us for our performance in Research & Development, where we ranked fifth. Our leading role in Intellectual Property sharing also received accolades.
The United Nations adopted 17 Sustainable Development Goals. Find out how we are contributing.Learn more
Access to Health Charter
To demonstrate our commitment to expanding access to healthcare we transparently publish dedicated charters.Learn more
Sustainable Supply Chains
We strengthen access to medicines in low- and middle-income countries by enhancing health supply chains.Learn more